This Data Rights Notice describes how Studio AGD processes personal data in accordance with the EU/UK General Data Protection Regulation (GDPR) and applicable United States privacy laws. Studio AGD provides pharmaceuticals and health education content at studioagd.com.
The data controller for personal data processed in connection with this website is: Studio AGD, c/o Martha Elena, 15425 Detroit Ave, Lakewood, OH 44107, United States. Contact: [email protected].
This notice applies to personal data we collect from visitors, subscribers, and individuals who contact us. It extends GDPR rights to individuals located in the EEA/UK where applicable, and outlines state-law rights for U.S. residents (e.g., CA, CO, CT, VA). Where GDPR and U.S. laws differ, we apply the protections required by the law that applies to you.
We use necessary cookies to operate the site and, where permitted, analytics cookies to measure performance and improve content. You can manage cookies via your browser settings and device controls. Where required by law, we will obtain your consent for non-essential cookies through a consent banner.
We do not sell personal data. We do not share personal data for cross-context behavioral advertising or targeted advertising as defined by U.S. state privacy laws.
We retain personal data only as long as necessary for the purposes described or as required by law. Typical retention periods are:
We may retain anonymized or aggregated information that does not identify you.
We share personal data with service providers acting under our instructions, including hosting providers, analytics platforms, security and performance tools, and customer communications services. These processors are bound by confidentiality and data protection obligations.
If personal data is transferred from the EEA/UK to the United States or other countries not deemed to provide an adequate level of protection, we rely on appropriate safeguards such as Standard Contractual Clauses and supplementary measures where required.
We implement appropriate technical and organizational measures to protect personal data, including encryption in transit, access controls, least-privilege practices, and regular monitoring for abuse or anomalies. No system can be guaranteed to be 100% secure; we maintain procedures to detect, respond to, and mitigate incidents.
Our content is intended for a general audience and is not directed to children under 13. We do not knowingly collect personal information from children under 13 (COPPA) or under the age applicable in the EEA/UK without appropriate consent. If you believe a child has provided personal data to us, please contact us at [email protected] and we will delete it.
Depending on your state of residence, you may have rights to:
Submit a request by emailing [email protected] or by mail to: Studio AGD, Attn: Data Rights, 15425 Detroit Ave, Lakewood, OH 44107, USA. Please specify the right you wish to exercise and provide sufficient information to verify your identity (e.g., your email address and the context of your interactions with us). Authorized agents may submit requests where permitted by law with proof of authorization and identity.
We will respond within one month under GDPR and within 45 days under applicable U.S. laws (with permissible extensions). We may request additional information solely to verify your identity and protect your privacy.
We do not engage in automated decision-making producing legal or similarly significant effects, nor do we conduct profiling in a way that triggers GDPR Article 22.
Studio AGD provides educational information about pharmaceuticals. We are not a HIPAA covered entity or business associate, and we do not request protected health information (PHI). Please do not submit sensitive medical information to us. If you voluntarily provide health-related details, we will use them only to address your inquiry and will minimize, restrict, and delete such data where feasible.
Where our processing presents a high risk to individuals, we will conduct Data Protection Impact Assessments and maintain records of processing activities as required by applicable law.
In the event of a personal data breach, we will notify competent authorities and affected individuals as required by law. For EEA/UK residents, we will notify supervisory authorities within 72 hours where required by GDPR and communicate with impacted individuals when the risk is high. For U.S. residents, we will comply with applicable state notification laws.
Studio AGD is established in the United States and does not regularly offer goods or services to, or monitor, individuals in the EEA/UK at scale. If our processing activities change such that Article 27 GDPR applies, we will designate an EU/UK representative and update this notice. In the meantime, EU/UK individuals may contact us directly at [email protected].
If you believe we have not handled your personal data in accordance with this notice or applicable law, you may contact us at [email protected]. You also have the right to lodge a complaint with your local supervisory authority (EEA/UK) or your state attorney general (U.S.).
We may update this Data Rights Notice from time to time to reflect changes in our practices or legal requirements. Material changes will be indicated by updating the effective date below.
Effective date: 2025-08-25
Written by Martha Elena
I'm a pharmaceutical research writer focused on drug safety and pharmacology. I support formulary and pharmacovigilance teams with literature reviews and real‑world evidence analyses. In my off-hours, I write evidence-based articles on medication use, disease management, and dietary supplements. My goal is to turn complex research into clear, practical insights for everyday readers.
All posts: Martha Elena